SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0000902664-24-003165
Filing Date
2024-05-02
Accepted
2024-05-02 06:48:38
Documents
1
Effectiveness Date
2024-05-02
Items
Item 06b:
Item 3C: Investment Company Act Section 3(c)
Item 3C.7: Section 3(c)(7)

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 15538
  Complete submission text file 0000902664-24-003165.txt   16840
Mailing Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012
Business Address 110 GREENE STREET SUITE 800 NEW YORK NY 10012 (212) 937-4975
Avoro Life Sciences Offshore Fund Ltd. (Filer) CIK: 0001498990 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-146407 | Film No.: 24905140